COPENHAGEN, Denmark, Aug. 22, 2022 - The BioInnovation Institute (BII), an international commercial non-profit foundation incubating and accelerating world-class life science research, today announces its investment into three international start-up companies from the UK, Germany, and Finland. The three new ventures are strategically aligned with the BII's focus, developing … [Read more...] about The BioInnovation Institute supports three international start-ups developing pioneering science in the therapeutics and health tech space
biotech
Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health
Investment from LifeArc, Illumina, and Illumina Ventures will fund genomics startups for Illumina Accelerator Cambridge graduates SAN DIEGO, June 28, 2022 - Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced its participation in Time Boost Capital I LP, a £30 million genomics venture fund dedicated to providing match … [Read more...] about Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health
Biotech companies have received significant VC funding in the past three years
Biotech companies 🧬 have received significant VC funding in the past three years. As a result, industry innovators have applied next-gen strategies to improve efficiency and ultimately reach more goals. Read our insights to learn more ➡️ https://t.co/MMFAcPTZ5L pic.twitter.com/08R11QyvJi— McKinsey & Company (@McKinsey) June 27, 2022 … [Read more...] about Biotech companies have received significant VC funding in the past three years
AgBiome Raises $116 Million Led By Blue Horizon and Novalis LifeSciences
AgBiome's Best-in-Class Microbial Platform Delivers Crop Protection Solutions to Feed the Growing Population Responsibly RESEARCH TRIANGLE PARK, N.C. - AgBiome, the leader in developing innovative products from the Earth's microbial communities, announced it has raised $116 million in an oversubscribed Series D round of funding, co-led by Blue Horizon and Novalis … [Read more...] about AgBiome Raises $116 Million Led By Blue Horizon and Novalis LifeSciences
Novalis Biotech Closes €25 Million Biotech Acceleration Fund
Second Healthcare Fund Invests in Start-ups and Scale-ups Advancing Transformative Healthcare Technologies GHENT, Belgium - (via OPINT) = Novalis Biotech, an early-stage venture capital investor in technologies aimed at revolutionizing healthcare, announced today the closing of its €25 million second fund, the Novalis Biotech Acceleration Fund. Both new and returning investors … [Read more...] about Novalis Biotech Closes €25 Million Biotech Acceleration Fund
Taiwanese Startups won 120 Millions USD from the US military, Hewlett-Packard and Johnson & Johnson
Taiwan's Ministry of Science and Technology Deputy Director-General Chun-Yi Tu first brought twelve biomedical startups to MedTech Conference 2019 in Boston, United States. During the exhibition, the teams received a total of 180 appointments with major medical manufacturers and academic institutions from around the world. The teams received orders totaling $120 million US … [Read more...] about Taiwanese Startups won 120 Millions USD from the US military, Hewlett-Packard and Johnson & Johnson
Ginkgo Bioworks Raises $290 Million in Series E Financing to Grow its Platform for Cell Programming, accelerates widespread adoption of synthetic biology, including new partnerships with startup accelerators Y Combinator and Petri
Today, Ginkgo Bioworks, the organism company, announced a Series E financing round of $290 million with participation from all existing major investors and other new investors including funds and accounts advised by T. Rowe Price Associates, Inc., bringing the company's total funding to $719 million. The latest round of funding will be used to further expand the reach of … [Read more...] about Ginkgo Bioworks Raises $290 Million in Series E Financing to Grow its Platform for Cell Programming, accelerates widespread adoption of synthetic biology, including new partnerships with startup accelerators Y Combinator and Petri
Mission Bay Capital Announces $60 Million Fund III
Mission Bay Capital, an early-stage life-science venture capital firm investing in innovative entrepreneurs working on vital medical and environmental challenges, announced the closing of its third fund today. Notable investors include Astellas Venture Management (a corporate venture capital of Astellas Pharma Inc.), Banyan Pacific Capital, Eli Lilly and Company, Mayfield, UC … [Read more...] about Mission Bay Capital Announces $60 Million Fund III
Platelet BioGenesis Raises $26 Million in Series A-1 Financing
Platelet BioGenesis, Inc. (PBG), the leader in stem cell-derived, on-demand human platelets (PLTs+™) and platelet-based therapeutics, announced today that it has raised more than $26 million in Series A-1 financing. This round – in addition to Series A financing and numerous grants – brings PBG’s total funding to approximately $45 million. Ziff Capital Partners (ZCP) and … [Read more...] about Platelet BioGenesis Raises $26 Million in Series A-1 Financing